ClinicalTrials.Veeva

Menu

Collection of Blood Specimens for Circulating Tumor Cell Analysis

V

Viatar

Status

Completed

Conditions

Breast Cancer
Prostate Cancer
Colorectal Cancer

Study type

Observational

Funder types

Industry
Other

Identifiers

NCT01943500
T30-0001

Details and patient eligibility

About

Objective: To test the sensitivity of a proprietary novel filtration device designed to capture and concentrate circulating tumor cells (CTCs).

Enrollment

14 patients

Sex

All

Ages

18+ years old

Volunteers

Accepts Healthy Volunteers

Inclusion criteria

  • Age > 18 years of age
  • Written informed consent obtained
  • Confirmed diagnosis of stage 2-4 breast, prostate, or colorectal cancer, (OR) no prior history of cancer
  • Stage 2-4 treatment naive, metastatic, secondary, and recurrent cancer patients
  • Able to undergo blood collection prior to initiation of chemotherapy treatment, (OR) able to provide blood sample if subject is a non-cancer control subject

Exclusion criteria

  • Patients unable to understand the research protocol and/or provide informed consent.
  • Patients with known immunodeficiency, or pregnancy.

Trial design

14 participants in 1 patient group

Cancer or no prior history of cancer
Description:
Confirmed patients with breast, prostate, or colorectal cancer (OR) subjects with no prior history of cancer

Trial contacts and locations

1

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2025 Veeva Systems